Our specialists participated in the “Conference of Research Workers in Animal Diseases 2020” held virtually last December 5-8. The “Conference of Research Workers in Animal Diseases 2020”, locally known as “CRWAD 2020 Conference” took place last December 5-8 in a virtual modality. Bioinnovo–Vetanco and Vetanco USA specialists…
Using two different platforms, Argentine researchers were able to neutralize the virus. Using “nanobodies” obtained from llamas and with egg immunoglobulins There is no doubt: only science will save the world from the COVID19 pandemic. And it is in this field where our researchers rank…
Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry of Productive Development, to increase the production of Vedevax Block in order to meet local demand and open new international markets. This is the first subunit vaccine…
Bioinnovo SA was part of a multidisciplinary team responsible for the development of avian IgY antibodies that neutralize the virus causing COVID-19 The project, “Development and production of critical reagents for COVID-19 diagnosis and treatment: Nanobodies, IgY polyclonal antibodies and recombinant proteins,” was undertaken by…
Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, has opened a new production plant for vaccines in the suburbs of Madrid*. The new facility has the capacity to manufacture up to 3.5 kg of recombinant proteins a…
Specialists of the National Institute of Industrial Technology (INTI) and the national company Ivema Desarrollos designed an essential device for a rapid diagnostic test to substitute imports, reduce costs to the half and meet the local demand that is currently with a shortage of stock. This device…
The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control of the virus. The product developed by Bioinnovo SA, a company created by a partnership between the National Institute of Agricultural Technology (INTA) of Argentina and the company Vetanco…
Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted by a scientific committee that brings together more than twenty male and female researchers from different institutions. Those institutions are the Institute of Science and Technology César Milstein (Conicet –…
Following the signing of a Memorandum of Understanding/Cooperation Agreement (MOU) between the MIT startup Sunflower and Bioinnovo, Kerry Love, PhD and Laura Crowell, PhD visited Vetanco at its corporate headquarters. The purpose of the meeting was to ratify the MOU, which detailed the scope of work optimizing several innovative platforms using…
Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter The renewed partnership provides Bioinnovo with the international rights to use Algenex’s APCH (antigen presenting cells homing) molecule in the _eld of animal health. Bioinnovo…